Search hospitals
>
New Mexico
>
Albuquerque
University of New Mexico Health Sciences Center
Claim this profile
Albuquerque, New Mexico 87102
Global Leader in I Am A Healthy Volunteer
Global Leader in Pulmonary Arterial Hypertension
Conducts research for COVID-19
Conducts research for Pulmonary Hypertension
Conducts research for Coronavirus
94 reported clinical trials
10 medical researchers
Summary
University of New Mexico Health Sciences Center is a medical facility located in Albuquerque, New Mexico. This center is recognized for care of I Am A Healthy Volunteer, Pulmonary Arterial Hypertension, COVID-19, Pulmonary Hypertension, Coronavirus and other specialties. University of New Mexico Health Sciences Center is involved with conducting 94 clinical trials across 252 conditions. There are 10 research doctors associated with this hospital, such as Davin Quinn, MD, Andrew Carlson, MD, Michel Torbey, MD, and Joao P Teixeira, MD.
Area of expertise
I Am A Healthy Volunteer
University of New Mexico Health Sciences Center has run 14 trials for I Am A Healthy Volunteer. Some of their research focus areas include:
Pulmonary Arterial Hypertension
University of New Mexico Health Sciences Center has run 12 trials for Pulmonary Arterial Hypertension.
Top PIs
Davin Quinn, MD
University of New Mexico
2 years of reported clinical research
Andrew Carlson, MD
University of New Mexico Hospital
3 years of reported clinical research
Michel Torbey, MD
The University of New Mexico - School of Medicine
15 years of reported clinical research
Joao P Teixeira, MD
University of New Mexico Health Sciences Center
2 years of reported clinical research
Clinical Trials running at University of New Mexico Health Sciences Center
Pulmonary Hypertension
Heart Failure
Stroke
Interstitial Lung Disease
Brain Arteriovenous Malformation
Arteriovenous Malformations
Pulmonary Embolism
Atrial Fibrillation
Pelvic Organ Prolapse
Obesity
Registry
for Pulmonary Hypertension
This is a prospective, non-interventional, multicenter, registry of patients with pulmonary hypertension associated with interstitial lung disease (PH-ILD).
Recruiting
1 award
N/A
10 criteria
Seralutinib
for Pulmonary Hypertension
This Phase 3 study is designed as a 24-week randomized, double-blind, placebo-controlled period (PCP) followed by a 144-week long-term extension (LTE) period. The primary objective of the PCP is to evaluate the effect of seralutinib on improving exercise capacity in subjects with World Health Organization (WHO) Group 3 pulmonary hypertension associated with interstitial lung disease. The primary objective of the LTE is to evaluate the long-term safety and tolerability of seralutinib.
Recruiting
1 award
Phase 3
2 criteria
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at University of New Mexico Health Sciences Center?
University of New Mexico Health Sciences Center is a medical facility located in Albuquerque, New Mexico. This center is recognized for care of I Am A Healthy Volunteer, Pulmonary Arterial Hypertension, COVID-19, Pulmonary Hypertension, Coronavirus and other specialties. University of New Mexico Health Sciences Center is involved with conducting 94 clinical trials across 252 conditions. There are 10 research doctors associated with this hospital, such as Davin Quinn, MD, Andrew Carlson, MD, Michel Torbey, MD, and Joao P Teixeira, MD.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.